Logo

Shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER11819Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults20.00 €
 Subtotal 20.00 €